What is a vegf antibody?
vegf means vascular endothelial growth factor, a substance that promotes blood vessel growth. An antibody is a special type of protein in the immune system, with receptors that connect to a specific harmful particle or antigen. VEGF antibody has receptors that bind to vegf and prevent it from working normally. VEGF helps tumors growing by increasing their blood supply and antibody VEGF can be used to treat cancer by blocking this effect. Bevacizumab is a vegf antibody used in the treatment of breast cancer. VeGF Bevacizumab antibody binds to a part of the vegf, which usually connects to receptors on the surface of endothelial cells. Endothelial cells are lined with blood vessels and when vegf bound to them, it causes changes and causes their multiplication, which eventually leads to the formation of new blood vessels. VEGF is prevented from connecting to endothelial cells when the Vegf antibody is connected to the binding point, so the growth of blood vessels is inhibited and the tumor growth is reduced.
When a vegf antibody in the form of bevacizumab is used to treat cancer, it is usually infused into a vein. Treatment can be administered together with chemotherapy and doses are administered at intervals of two or three weeks. There may be side effects that may include fatigue, nausea, diarrhea and increased blood pressure. Patients sometimes experience a response to an infusion with rash, fever, swelling and wheezing, but this can often be treated simply by stopping the procedure.
The medicine Bevacizumab is an example of a monoclonal antibody, the only type of antibody produced by a commercial production company Antibodies. Monoclonal antibodies are produced only by one line B cells in the immune system, while polyclonal antibodies are products more than one type of B cells. Bevacizumab is also an example of unconjugated antibodies that are not associated with another substance, such as a drug, cancer destruction or radioactive material.
Conjugation AntilateThe EC is sometimes carried out by companies to create controlled missiles consisting of antibody and toxic material. The antibody provides a destructive substance directly to the target such as a cancer cell, which reduces its effect on healthy cells. Companies can examine antibodies, develop them for therapeutic use and produce antibodies on a large scale. Such suppliers of antibodies can offer a number of antibodies in the antibodies catalog or can create their own products.